News | September 17, 2025
ProBioGen to spearhead GMP manufacturing at Berlin’s gene & cell therapy hub
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
IND application for EB-003 expected in early 2026
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
RN3161 is engineered to reduce fat while preserving lean mass, setting it apart from current treatment options
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Subscribe To Our Newsletter & Stay Updated
